ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/003/ERR6896663/ERR6896663.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/005/ERR6896665/ERR6896665.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/001/ERR6896661/ERR6896661.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/009/ERR6896659/ERR6896659.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/004/ERR6896654/ERR6896654.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/000/ERR6896650/ERR6896650.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/005/ERR6896655/ERR6896655.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/000/ERR6896660/ERR6896660.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/007/ERR6896657/ERR6896657.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/001/ERR6896671/ERR6896671.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/002/ERR6896652/ERR6896652.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/008/ERR6896668/ERR6896668.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/004/ERR6896664/ERR6896664.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/001/ERR6896651/ERR6896651.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/006/ERR6896666/ERR6896666.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/008/ERR6896658/ERR6896658.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/002/ERR6896662/ERR6896662.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/003/ERR6896673/ERR6896673.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/006/ERR6896656/ERR6896656.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/002/ERR6896672/ERR6896672.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/009/ERR6896669/ERR6896669.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/007/ERR6896667/ERR6896667.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/000/ERR6896670/ERR6896670.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR689/003/ERR6896653/ERR6896653.fastq.gzprimaryOK200GenomicsEuropean Bioinformatics InstituteDepartment of Translational Genomics, University of Colognehttps://www.ebi.ac.uk/ena/browser/view/PRJEB47888ArrayExpressIn the human EGFR mutant adenocarcinoma cell line PC9 pBabe empty vector (EV) or BRAF V600E were overexpressed. RNA was extracted from EV, BRAF V600E overexpressing or osimertinib-resistant BRAF V600E expressing cells after 48h treatment with osimertinib, trametinib, a combination of both or vehicle controls. RNA was subjected to 3' UTR RNA sequencing.ENAfalse3' RNAseq of EGFR mutant lung cancer cell line overexpressing BRAF V600E treated with inhibitors3' RNAseq of EGFR mutant lung cancer cell line overexpressing BRAF V600E treated with inhibitors2021-10-202021-10-20PRJEB47888